China to strengthen regulations for excipient manufacturers

05/5/2013 | In-PharmaTechnologist.com

The China Food and Drug Administration has established new licensing requirements for the manufacture of high-risk excipients based on toxicity and dosage. The new rules are part of a broader effort to establish a drug master file system similar to the U.S. FDA's. The capacity of China's FDA to register and inspect pharmaceutical and excipient manufacturers is limited and would benefit from third-party audits and stronger self-policing, according to Meredith Ge, former chairwoman of the International Pharmaceutical Excipients Council, who spoke at IPEC-Americas' Excipient Fest in Baltimore.

View Full Article in:

In-PharmaTechnologist.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR CLINICAL RESEARCH - 14000003MB
Abbott
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA